Cargill Sells Cultures and Enzymes Business to DSM

Royal DSM, a company focused on life sciences and materials sciences, acquired Cargill’s cultures and enzymes business, a move that will allow DSM to become a global, tier-one supplier of dairy ingredients. DSM anticipates that the acquisition will also help it work toward biotechnology innovations.

As quoted in the press release:

The cultures and enzymes business of Cargill is a global leading manufacturer of cultures and enzymes for the dairy and meat industries with manufacturing operations in Wisconsin (USA) and France. It has a strong pipeline of new products built on three pillars of technology: culture texture toolbox, fast acidification for cheese yield improvements and culture flavor systems. The business generates net sales of about €45 million per year with approximately 200 employees.

The market for cultures and enzymes is valued at over €1 billion, growing steadily at more than 5% per annum. Applications are primarily found in dairy products which continue to have a healthy and tasty appeal to consumers worldwide.

Click here to read the full Royal DSM press release.